WIEDERMANNOVA, Hana, Peter MÚDRY, Jan PAVLICEK, Hana TOMASKOVA, Andrea HLADIKOVA, Hana PÁLOVÁ, Petra POKORNÁ, Ondřej SLABÝ and Jaroslav ŠTĚRBA. Risk factors for tumors or leukemia development in the first two years of life. Biomedical Papers, Olomouc: Palacky University. Olomouc: Palacky University, 2023, vol. 167, No 2, p. 246-253. ISSN 1213-8118. Available from: https://dx.doi.org/10.5507/bp.2022.004.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Risk factors for tumors or leukemia development in the first two years of life
Authors WIEDERMANNOVA, Hana (203 Czech Republic), Peter MÚDRY (203 Czech Republic, belonging to the institution), Jan PAVLICEK (203 Czech Republic, guarantor), Hana TOMASKOVA (203 Czech Republic), Andrea HLADIKOVA (203 Czech Republic), Hana PÁLOVÁ (203 Czech Republic, belonging to the institution), Petra POKORNÁ (203 Czech Republic, belonging to the institution), Ondřej SLABÝ (203 Czech Republic, belonging to the institution) and Jaroslav ŠTĚRBA (203 Czech Republic, belonging to the institution).
Edition Biomedical Papers, Olomouc: Palacky University, Olomouc, Palacky University, 2023, 1213-8118.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30205 Hematology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 0.900 in 2022
RIV identification code RIV/00216224:14110/23:00130240
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.5507/bp.2022.004
UT WoS 000757422200001
Keywords in English neoplastic disease; epidemiology; risk factors; early-aged period
Tags 14110321, 14110513, CF GEN, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Eva Dubská, učo 77638. Changed: 8/4/2024 10:26.
Abstract
Objectives. The objective of this study was to determine the incidence of neoplastic diseases and associated risk factors in the early stages of life. Methods. Data were retrospectively assessed in 730,000 live births between 2000 and 2019. The occurrence of tumors was monitored in the neonatal, infant (1-12 months), and toddler (13-24 months) periods. Risk factors were divided into demographic, internal, and environmental factors. The control group consisted of subjects in the same age category without oncological diseases. Results. A total of 452 neoplastic diseases were diagnosed in the study sample. In total, 24% (110/452) manifested during the neonatal period, 45% (203/452) in infants, and 31% (139/452) at the age of 13-24 months. Any genetic disease (OR 26.68; 95% CI 7.64-93.12) and medications used by the mother (OR 3.07; 95% CI 1.32-7.15) were identified as risk factors. Without adjustment for all factors, asphyxia in the first minute, a younger age of the mother, lower pregnancy, and the presence of a congenital defect manifested themselves as risk factors. Conclusions. The highest risk factors for the development of early childhood tumors were identified as with medications used by the mother before or during pregnancy and genetic diseases.
Links
LM2015091, research and development projectName: Národní centrum lékařské genomiky (Acronym: NCLG)
Investor: Ministry of Education, Youth and Sports of the CR
MUNI/A/1427/2021, interní kód MUName: Personalizovaná léčba v dětské onkologii: na cestě k „liquid dynamic medicine“ a „N-of-1 clinical trials“
Investor: Masaryk University
NU20-03-00240, research and development projectName: Celoexomové sekvenování, sekvenování genomu s nízkým pokrytím a transkriptomu pro účely precizní onkologie u dětských pacientů s vysoce rizikovými a relabovanými solidními nádory
Investor: Ministry of Health of the CR, Whole exome, low-coverage genome and transcriptome sequencing as tools for precision oncology in paediatric patients with high-risk and relapsed solid tumors, Subprogram 1 - standard
90267, large research infrastructuresName: NCMG III
PrintDisplayed: 18/7/2024 04:20